TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/10/23 18:10 | 3/8/23 | JAZZ | Jazz Pharmaceuticals Plc | L2 | Health | Drug | Pharmaceutical Preparations | Sablich Kim | L2 | O | EVP,GM o | S | -421 | 139.74 | 0 | -3 | -9 | 31 | D | ||||||||||||||
6/8/22 16:56 | 6/6/22 | JAZZ | Jazz Pharmaceuticals Plc | L2 | Health | Drug | Pharmaceutical Preparations | Sablich Kim | L2 | O | EVP,GM,N | S.m | -580 | 151.45 | 0 | -4 | -13 | 25 | D | ||||||||||||||
11/15/21 19:30 | 11/11/21 | JAZZ | Jazz Pharmaceuticals Plc | L2 | Health | Drug | Pharmaceutical Preparations | Sablich Kim | L2 | O | EVP,GM,N | S | -371 | 135.01 | 0 | -3 | -12 | 21 | D | ||||||||||||||
3/19/20 16:32 | 3/18/20 | MYOV | Myovant Sciences Ltd. | CA | Health | Drug | Pharmaceutical Preparations | Sablich Kim | CA | O | Chief Co | S | -6 | 7.37 | 0 | -1 | -1 | 59 | D | ||||||||||||||
1/16/20 17:28 | 1/15/20 | MYOV | Myovant Sciences Ltd. | CA | Health | Drug | Pharmaceutical Preparations | Sablich Kim | CA | O | Chief Co | S | -68 | 14.04 | 0 | -5 | -8 | 60 | D | ||||||||||||||
12/19/19 16:25 | 12/18/19 | MYOV | Myovant Sciences Ltd. | CA | Health | Drug | Pharmaceutical Preparations | Sablich Kim | CA | O | Chief Co | S | -42 | 16.22 | 0 | -3 | -4 | 65 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |